Methylprednisolone Prevention of Increased Lung Vascular Permeability following Endotoxemia in Sheep

To see whether methylprednisolone would affect the pulmonary vascular response to endotoxemia, we studied responses to endotoxemia in the presence and absence of methylprednisolone in the same chronically instrumented, unanesthetized sheep. Infusion of Escherichia coli endotoxin (0.70-1.33 μg/kg) caused an initial period of marked pulmonary hypertension followed several hours later by a long period of increased vascular permeability when pulmonary vascular pressures were near base line (base-line pulmonary artery pressure (PPa) = 21±1 cm H₂O SE, left atrial pressure (Pla) = 1±3; experimental PPa = 20±3, Pla = 3±4; P = NS), lung lymph flow (˙Qlym) was high (base-line ˙Qlym = 7.2±0.2 ml/h; experimental ˙Qlym = 23.2±1.0; P < 0.05) and lymph/plasma protein concentration (L/P) was high (base-line L/P = 0.65±0.04; experimental L/P = 0.79±0.05; P < 0.05). When methylprednisolone (1.0 g + 0.5 g/h i.v.) was begun 30 min before the same dose of endotoxin was infused, the initial pulmonary hypertension was less and the late phase increase in lung vascular permeability was prevented (experimental PPa = 24±1, Pla = 1±1, ˙Qlym = 10.0±0.4; L/P = 0.56±0.03). ˙Qlym and L/P were significantly (P < 0.05) lower than with endotoxin alone. Methylprednisolone began during the initial pulmonary hypertensive response to endotoxin also prevented the late phase increase in lung vascular permeability, but the drug had no effect once vascular permeability was increased. We conclude that large doses of methylprednisolone given before or soon after endotoxemia prevent the increase in lung vascular permeability that endotoxin causes, but do not reverse the abnormality once it occurs.

Click on an image below to see the page. View PDF of the complete article

page 1103

page 1104

page 1105

page 1106

page 1107

page 1108

page 1109

page 1110